Elevate Medical Affairs Podcast Channel

Using Real-World Data to Understand Patient Journeys in Dermatology

November 17, 2022 Medical Affairs Professional Society Season 2022 Episode 44
Using Real-World Data to Understand Patient Journeys in Dermatology
Elevate Medical Affairs Podcast Channel
More Info
Elevate Medical Affairs Podcast Channel
Using Real-World Data to Understand Patient Journeys in Dermatology
Nov 17, 2022 Season 2022 Episode 44
Medical Affairs Professional Society

Post-approval safety studies have traditionally been cumbersome and expensive, and safety study sites are likely to mirror those used in clinical trials, leading organizations to potentially miss safety signals in populations beyond those that typically participate at trial sites. Here we speak with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about a transformation in the way we conduct safety studies — relying on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.

Show Notes

Post-approval safety studies have traditionally been cumbersome and expensive, and safety study sites are likely to mirror those used in clinical trials, leading organizations to potentially miss safety signals in populations beyond those that typically participate at trial sites. Here we speak with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about a transformation in the way we conduct safety studies — relying on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.